Systemic actions: They are both found in several tissues, as well as in circulation, where they modulate metabolism, oxidative stress, cell survival, and inflammation
Remember, results may vary, and its important to stay consistent and realistic in your expectations
However, from 1 January 2026, markers of tirzepatide (Mounjaro/Zepbound) were added to WADA's Monitoring Program
Consequently, once-daily subcutaneous administration of liraglutide 3.0 mg was developed for the treatment of obesity [21] and once-weekly subcutaneous administration of semaglutide 2.4 mg is currently being investigated in phase III trials for this indication [22]
Tailored Solutions: We understand that every individual is unique